Related Experiment Video
Updated: Jan 30, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Drug Repurposing for Retinoblastoma: Recent Advances
Kamakshi Dandu1,2, Prathap R Kallamadi3, Suman S Thakur1
1CSIR-Centre for Cellular and Molecular Biology, Uppal Road, Habsiguda, Hyderabad 500 007, India.
Drug repurposing offers a faster alternative to develop new treatments for retinoblastoma, a childhood eye cancer. This review explores existing drugs, like calcium channel blockers and anti-inflammatories, for potential use against this malignancy.
Area of Science:
- Oncology
- Ophthalmology
- Pharmacology
Background:
- Retinoblastoma is a primary intraocular malignancy in early childhood.
- Current treatments (chemotherapy, focal therapies, enucleation) have significant side and late effects.
- There is a critical need for safer and more effective retinoblastoma therapies.
Purpose of the Study:
- To review drug repurposing strategies for retinoblastoma treatment.
- To explore existing drugs approved for other conditions as potential retinoblastoma therapies.
- To identify promising drug candidates for future repurposing efforts.
Main Methods:
- Literature review of studies investigating drug repurposing for retinoblastoma.
- Categorization of repurposed drugs by their original therapeutic class (e.g., calcium channel blockers, NSAIDs, antidiabetics).
- Discussion of the potential of various drug classes and novel candidates.
Main Results:
- Several drug classes, including calcium channel blockers, non-steroidal anti-inflammatory drugs (NSAIDs), cardenolides, antidiabetics, antibiotics, and antimalarials, have been investigated for retinoblastoma treatment.
- Drug repurposing presents a faster and more cost-effective alternative to conventional drug development.
- Various existing medications show promise for treating retinoblastoma.
Conclusions:
- Drug repurposing is a viable and promising strategy to identify novel, safer treatments for retinoblastoma.
- Exploring existing drug approvals can accelerate the development of new therapeutic options for this childhood eye cancer.
- Further research into specific drug candidates and combinations is warranted to optimize retinoblastoma treatment.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Extraction: Advanced Methods
Sample Preparation for Analysis: Advanced Techniques
Acid digestion with strong acids is commonly used to dissolve inorganic materials that are insoluble (do not dissolve) in water. This method can be useful for...
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Pharmacokinetics: Drug–Drug Interactions

